68 Ga PSMA PET/MRI for Hepatocellular Carcinoma

  • End date
    Jun 1, 2022
  • participants needed
  • sponsor
    Ajit H. Goenka, MD
Updated on 26 January 2021
liver transplant
pet scan


This is a pilot study to investigate the evaluate to use of a drug/radiopharmaceutical called Gallium-68 PSMA-11 (68Ga-PSMA-11) for use in PET/MRI evaluation of hepatocellular carcinoma


This is a prospective pilot proof-of-concept single-center study. Primary Objective Using surgical histopathology as the reference standard, the investigators intend to achieve the following objectives in adult subjects with Hepatocellular Carcinoma (HCC) undergoing surgical resection or transplant:

  1. To demonstrate the feasibility of 68Ga-PSMA-PET/MRI for imaging patients with HCC
  2. To estimate the sensitivity of SUVmax on PSMA PET for identification of LI-RADS 5 (definitely HCC) observations or biopsy proven HCC(s).
  3. To perform a Radiology-Pathology correlation of PSMA uptake at PET with HCC tumor PSMA immunostaining, tumor pathology features, and signal and enhancement characteristics at MRI

Condition Adenocarcinoma, HEPATIC NEOPLASM, HEPATOCELLULAR CARCINOMA, Liver Cancer, Malignant Adenoma, liver cell carcinoma
Treatment 68Ga-PSMA-11 PET/MRI
Clinical Study IdentifierNCT03982407
SponsorAjit H. Goenka, MD
Last Modified on26 January 2021


Yes No Not Sure

Inclusion Criteria

Patients at risk for HCC with either an imaging diagnosis of HCC by ceCT or ceMRI (LI-RADS 5) confirmed by a board-certified abdominal radiologist or biopsy-proven HCC confirmed by a hepatobiliary pathologist
No prior treatment for HCC
Subjects who are expected to undergo surgical resection of the hepatic lesion(s) and/or liver transplant
Male or female with age greater than 18 years, with the capacity to give informed consent and willingness to provide a written consent

Exclusion Criteria

Subjects requiring emergent surgery for a ruptured/bleeding HCC
Bilirubin > 3.0 mg/dL, which is a contraindication for Gadoxetate, the MRI contrast agent
Pregnant and/or breast-feeding subjects. A negative pregnancy test within 48 hours of the PET scan
Subjects with higher than the weight/size limitations of PET/MRI scanner
Subjects with contraindication to MRI including: Subjects who have a heart pacemaker, subjects who have a metallic foreign body (metal sliver) in their eye, or who have an aneurysm clip in their brain, subjects who have implanted devices with magnets, subjects who have other implanted electronic devices, subjects who have deep brain stimulator, subjects who have vagal nerve stimulator, subjects with cochlear (ear) or auditory implants
Subjects with history of allergic response to radiocontrast media
Subjects with known history of claustrophobia
Clear my responses

How to participate?

Step 1 Connect with a site
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact


Preferred Language
Other Language
Please verify that you are not a bot.

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note